Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

7 Jul 2020 07:00

RNS Number : 1660S
Assura PLC
07 July 2020
 

7 July 2020

Assura plc

 

Trading Update

For the first quarter ending 30 June 2020

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter ending 30 June 2020.

 

Jonathan Murphy, CEO, said:

"We've had an active first quarter, as we continued to deliver strategic and financial progress across all areas of the business, despite these uncertain times for the UK. Our business model remains resilient and robust, as demonstrated by normal patterns of recent rent collections and all our development sites being active in line with social distancing guidelines.

"Our social purpose - to create outstanding primary care properties that sit at the heart of our local communities - has never been more important than it is today, and we are making good progress with our recently launched sixbysix social impact strategy.

"As lockdown restrictions gradually ease, we are working closely with our GP partners to ensure we best support the NHS and respond to evolving market needs as part of the 'new normal'. Primary care will play a crucial role as the UK seeks to rebuild and recover from the COVID-19 crisis and we are engaging with Government to ensure that it remains a key area of investment going forward."

 

Operational update

· Safety and wellbeing of our colleagues, tenants and patients our top priority

· Ongoing discussions with our tenants and the NHS on how our buildings can best support the evolving needs of GPs and patients as we gradually move out of the lockdown

· All construction sites active with appropriate social distancing measures in place

· June quarter rents being received in line with normal patterns

 

Active first quarter

· Strong portfolio of 565 properties with current annualised rent roll of £110.2 million

· Developments at Stafford and Netherfield completed (combined cost £11.9 million) - the latter is on track for a BREEAM rating of "Excellent", incorporating a number of sustainable elements including electric vehicle charging points, photovoltaic panels and an air source heat pump

· Five schemes progressed to on-site, including Stourport in Worcestershire which is part funded by NHS England's Estates and Technology Transformation Fund ("ETTF")

· Seven acquisitions completed for combined £35 million

· Portfolio of 20 assets disposed for £17 million, as disclosed in our year end results in May

· Two lease regears completed (£0.3 million of existing rent)

· One capital asset enhancement project completed and three currently on site (combined spend £0.6 million)

 

Strong pipeline for growth

· Currently on-site with 18 developments with a total cost of £95 million

· Immediate development pipeline totalling £60 million: schemes which we expect to be on site within 12 months

· Immediate acquisitions pipeline stands at £51 million, which we would normally expect to complete in three-six months

· 45 lease re-gears covering £5.6 million of existing rent roll in the current pipeline

· Pipeline of 21 capital asset enhancement projects (projected spend £15 million) over the next two years

 

Robust balance sheet

· At 30 June 2020 gross debt stood at £767 million with undrawn facilities of £300 million

· As announced with our year end results in May, the maturity of the revolving credit facility has been extended to November 2025, with the facility reducing from £300 million to £225 million with effect from May 2021

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 680

Email: Investor@assura.co.uk

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

Email: Assura@Finsbury.com

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at £2,139 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFESDDIRIII
Date   Source Headline
21st Mar 20167:00 amRNSDirector/PDMR Shareholding
15th Mar 201611:54 amRNSDirector/PDMR Shareholding
10th Mar 20167:00 amRNSNotice of Dividend
4th Mar 20167:00 amRNSFurther statement regarding Graham Roberts
29th Feb 20167:00 amRNSDirector Declaration
9th Feb 20167:05 amRNSTrading Update
9th Feb 20167:00 amRNSStatement regarding Chief Executive Graham Roberts
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20162:00 pmRNSNotification of Vesting of Share Award to PDMR
22nd Jan 20167:00 amRNSAcquisition and Issue of Consideration Shares
19th Jan 20162:12 pmRNSScrip Dividend Declaration
6th Jan 20167:00 amRNSDirector/PDMR Shareholding
24th Dec 20157:00 amRNSScrip Calculation Price
22nd Dec 20155:06 pmRNSDirector/PDMR Shareholding
9th Dec 20157:00 amRNSNotice of Dividend & Introduction of Scrip Scheme
19th Nov 20157:00 amRNSInterim Results 2015
12th Nov 20157:00 amRNSDebt Redemption
2nd Nov 201512:14 pmRNSAcquisition and Issue of Consideration Shares
15th Oct 20151:53 pmRNSNotification of Major Interest in Shares
14th Oct 20155:10 pmRNSDirector/PDMR Shareholdings
13th Oct 201511:58 amRNSConfirmation of Quarterly Interim Dividend
12th Oct 20152:27 pmRNSResult of General Meeting
12th Oct 20157:00 amRNSResult of Proposed Share Issue
1st Oct 20159:59 amRNSTotal Voting Rights
28th Sep 20155:49 pmRNSPDMR Sale of Shares under VCP
25th Sep 20155:50 pmRNSAward and Exercise of Nil Cost Options under VCP
24th Sep 20154:53 pmRNSPublication of Prospectus
24th Sep 20157:00 amRNSProposed Share Issue and Notice of GM
8th Sep 20155:41 pmRNSTR1 Notification of Major Interest in Shares
13th Aug 201511:02 amRNSAnnual Information Update
21st Jul 20155:44 pmRNSResult of AGM
21st Jul 20154:00 pmRNSAcquisition and Issue of Consideration Shares
21st Jul 20157:00 amRNSTrading Update
18th Jun 20157:00 amRNSConfirmation of Quarterly Interim Dividend
17th Jun 20152:53 pmRNSCompany Secretary Appointment
2nd Jun 201512:58 pmRNSNotification of Major Interest In Shares
21st May 20157:00 amRNSFull Year Results
7th May 201512:10 pmRNSNotification of Major Interest in Shares
1st May 20153:28 pmRNSNotice of Results
15th Apr 20154:11 pmRNSNotification of Major Interest in Shares
14th Apr 20155:39 pmRNSNotification of Major Interest in Shares
2nd Apr 20155:09 pmRNSConfirmation of Quarterly Interim Dividend
26th Mar 201511:16 amRNSDirector/PDMR Shareholding
6th Mar 20158:50 amRNSEPRA Index Inclusion
4th Feb 20157:00 amRNSTrading Update
30th Jan 20159:42 amRNSNotification of Major Interest in Shares
29th Jan 20153:56 pmRNSNotification of Vesting of Share Award to PDMR
28th Jan 20158:21 amRNSAdmission of Assura plc shares
27th Jan 20151:53 pmRNSCourt hearing approves new corporate structure
23rd Jan 20152:27 pmRNSPublication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.